PBH

Business Context and Reporting Period

Company: Prestige Brands Holdings, Inc. (Prestige Consumer Healthcare Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2009
Business Overview: The Company markets, sells, and distributes brand-name over-the-counter (OTC) healthcare, household cleaning, and personal care products. It operates through three segments: OTC Healthcare (56.6% of revenue), Household Cleaning (37.1%), and Personal Care (6.3%). The Company utilizes an asset-light model, outsourcing manufacturing and distribution to third parties while focusing on marketing, sales, and product innovation.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Total revenues decreased 4.3% to $312.7 million, driven by declines across all segments. OTC Healthcare revenue fell 3.7%, Household Cleaning fell 4.2%, and Personal Care fell 9.5%. The decline was attributed to weaker consumer consumption, pricing pressures, and the absence of the Wartner acquisition impact seen in prior years.
• Significant Impairment Charge: The Company recorded a non-cash impairment charge of $249.6 million ($190.7 million for goodwill and $58.9 million for intangible assets). This charge was a direct consequence of the challenging economic environment, dislocation of debt/equity markets, and contracting consumer demand, which caused the carrying value of assets to exceed their fair value.
• Net Loss: The Company reported a net loss of $186.8 million compared to net income of $33.9 million in 2008. Excluding the impairment charge, the Company would have reported adjusted net income of approximately $33.3 million.
• Improved Cash Flow: Despite the net loss, cash provided by operating activities increased 48% to $66.7 million, primarily due to the non-cash nature of the impairment charge and improved working capital management (decrease in accounts receivable and inventory).
• Debt Reduction: Total indebtedness decreased by $32.9 million to $378.3 million as the Company used free cash flow to repay $29.3 million of debt in excess of scheduled maturities.

Guidance, Outlook, Risks, and Unusual Items

• Liquidity Strategy: Management prioritized liquidity due to the expiration of the $60 million Revolving Credit Facility in April 2009 and tight credit markets. The Company accumulated a $30 million cash cushion and limited voluntary debt repayments in the latter half of the fiscal year.
• Refinancing Risk: The Company must refinance its credit facilities. Management anticipates that refinancing rates will exceed the current average borrowing rate of 4.93% due to market conditions. There is no assurance that financing will be available on favorable terms.
• Customer Concentration: The top five customers accounted for 47% of gross sales in 2009, with Wal-Mart alone representing approximately 26%. The loss of a major customer could materially impact results.
• Manufacturing Dependence: The Company relies entirely on third-party manufacturers. Approximately 28% of gross sales were produced by manufacturers with whom the Company had no long-term contracts, exposing the business to supply disruption or cost increases.
• Legal Proceedings:
  • Securities Class Action: A consolidated class action lawsuit regarding the 2005 IPO reached an agreement in principle to settle, with funds expected to come from insurance proceeds.
  • DenTek Litigation: Ongoing intellectual property litigation against DenTek Oral Care, Inc. and others regarding "The Doctor's NightGuard" product. The litigation was temporarily stayed due to a defendant's bankruptcy filing.
• Unusual Items: The $249.6 million impairment charge is the primary unusual item. Additionally, the Company reversed $898,000 of previously recorded stock-based compensation costs in 2009 because performance goals were not met.

Investor Verification Checklist

• Refinancing Status: Verify the status of the refinancing for the expired Revolving Credit Facility and the Tranche B Term Loan Facility maturing in April 2011.
• Asset Valuation: Assess the sustainability of the remaining goodwill and intangible asset values ($691.8 million) given the significant impairment already taken and the ongoing economic downturn.
• Customer Concentration: Monitor sales trends specifically with Wal-Mart (26% of sales) and the top 10 customers (59% of sales) to gauge revenue stability.
• Supply Chain Contracts: Review the status of contracts with third-party manufacturers, particularly for the 28% of sales lacking long-term agreements.
• Legal Settlements: Confirm the final approval and terms of the securities class action settlement and the resolution of the DenTek litigation.